Estimation of renin and d-dimer levels in women with polycystic ovary disease with or without coronavirus infection
-
Published:2022-11-07
Issue:
Volume:
Page:
-
ISSN:2706-9915
-
Container-title:Baghdad Journal of Biochemistry and Applied Biological Sciences
-
language:
-
Short-container-title:Baghdad J. Biochem. Appl. Biol. Sci.
Author:
Ali Shaimaa,Khaleel Fayhaa,Ali Farah
Abstract
Background and objective: Polycystic ovarian syndrome (PCOS) is a common endocrinologic disorder among women of childbearing age. Coronavirus disease 2019 (COVID-19) is an acute respiratory disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This study aimed to determine the levels of renin, d-dimer, and some relevant biomarkers in patients with PCOS (with and without COVID-19) compared with non-PCOS patients (with and without COVID-19).
Methods: This cross-sectional study included 120 women [80 PCOS women (40 with COVID-19 and 40 without COVID-19) and 40 non-PCOS women (20 with COVID-19 and 20 without)] with age range of 15–40 years old. Blood samples were collected from participants, and biochemical assays were carried out. Renin and d-dimer levels were determined using the enzyme-linked-immunosorbent-assay (ELISA), lipid-profile and fasting blood glucose concentrations were assessed by using the colorimetric methods, and hormones were evaluated by VIDAS.
Results: Renin and d-dimer levels were found to be significantly higher in PCOS-women groups compared to non-PCOS group. In addition, the results showed that hormones, fasting blood glucose, and lipid-profile are significantly increased in PCOS patients compared to non-PCOS women, while high-density-lipoprotein and follicle-stimulating-hormone levels were low when comparing PCOS patients with non-PCOS ones. The results also showed that a highly significant increase in renin and d-dimer levels can be detected in PCOS patients with COVID-19.
Conclusions: In the present study, we found there is a possible relationship between renin and d-dimer in PCOS patients who are also COVID-19 infected.
Publisher
Department of Chemistry and Biochemistry, Al-Nahrain University
Reference33 articles.
1. Cooney, L.G. and Dokras, A., 2017. Depression and anxiety in polycystic ovary syndrome: etiology and treatment. Current psychiatry reports, 19(11), pp.1-10. 2. McCartney, C.R. and Marshall, J.C., 2016. Polycystic ovary syndrome. New England Journal of Medicine, 375(1), pp.54-64. 3. Doroszewska, K., Milewicz, T., Mrozińska, S., Janeczko, J., Rokicki, R., Janeczko, M., Warzecha, D. and Marianowski, P., 2019. Blood pressure in postmenopausal women with a history of polycystic ovary syndrome. Menopause Review/Przegląd Menopauzalny, 18(2), pp.94-98. 4. Harnois-Leblanc, S., Hernandez, M.I., Codner, E., Cassorla, F., Oberfield, S.E., Leibel, N.I., Mathew, R.P., Ten, S., Magoffin, D.A., Lane, C.J. and Goran, M.I., 2022. Profile of Daughters and Sisters of Women With Polycystic Ovary Syndrome: The Role of Proband’s Glucose Tolerance. The Journal of Clinical Endocrinology & Metabolism, 107(3), pp.e912-e923. 5. Janse F, Fauser BC. Pregnancy Complications and Children Outcomes in Patients with Polycystic Ovarian Syndrome. Polycystic Ovary Syndrome. 2022 Feb 28:131.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|